Showing results (241-250 of 5,003) with videos related to
Sort By:
Pageof 501
American Journal of Clinical Oncology|December 1, 1996
Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancerE Baldini, C Tibaldi, E Pfanner, et al.American Journal of Clinical Oncology|December 1, 1996
Preliminary report of outpatient weekly adjuvant chemotherapy for high-risk nasopharyngeal carcinomaJ C Lin, J S Jan, C Y HsuAmerican Journal of Clinical Oncology|April 1, 1997
Squamous cell head and neck cancer in nonsmokersE H Tan, D J Adelstein, M L Droughton, et al.American Journal of Clinical Oncology|April 1, 1997
Filgrastim and lack of support of intensive adjuvant chemotherapy for high-risk breast cancer patientsE Baldini, C Tibaldi, M Lencioni, et al.American Journal of Clinical Oncology|April 1, 1997
Randomized trial of filgrastim vs. sequential filgrastim and molgramostim after dose-intensified carboplatin, cyclophosphamide, and etoposide: a phase I pilot studyF Recchia, S De Filippis, P Torchio, et al.American Journal of Clinical Oncology|December 1, 1989
Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind crossover trial with metoclopramide and placeboC F Pollera, M Nardi, P Marolla, et al.American Journal of Clinical Oncology|October 6, 2010
General selection criteria of patients for radioembolization of liver tumors: an international working group reportDouglas Coldwell, Bruno Sangro, Harpreet Wasan, et al.American Journal of Clinical Oncology|February 1, 2011
Results of the 2005 to 2008 Association of Residents in Radiation Oncology surveys of chief residents in the United States: didactics and research experienceVinai Gondi, Johnny Ray Bernard, Siavash Jabbari, et al.American Journal of Clinical Oncology|January 11, 2011
Dual blockade of the EGFR and COX-2 pathways: a phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancerEmily Chan, Bonnie Lafleur, Mace L Rothenberg, et al.American Journal of Clinical Oncology|January 11, 2011
Predictive ability of Charlson comorbidity index on outcomes from lung cancerApar Kishor Ganti, Emily Siedlik, Alissa S Marr, et al.Pageof 501